AI Health Startup Caresyntax Raises $180M to Bring AI Smarts to the Operating Room

Caresyntax, a leading vendor-neutral precision surgery platform, has announced a significant funding round of $180 million. The financing, which includes a Series C extension and growth debt expansion, comprises $80 million in equity and up to $100 million in growth debt facility.

The funding round attracted a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, and several others.

Caresyntax's platform aims to transform surgery by implementing a scalable, end-to-end software and AI solution. The medical-grade, interoperable platform captures novel data and provides applications to enhance surgical precision and patient safety. Currently, Caresyntax serves over 30,000 surgical professionals across more than 3,000 operating rooms worldwide.

Himani Bhalla, Chief Investment Officer of Symbiotic Capital, expressed enthusiasm for the investment, stating, "Symbiotic is thrilled to support Caresyntax in its mission to enhance surgical outcomes through its innovative platform, delivering benefits to stakeholders throughout the healthcare ecosystem. We were impressed with Caresyntax's growth across hospitals, medtechs and insurers and look forward to working together to continue to scale their platform."